Docoh
Loading...

INDP Indaptus Therapeutics

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.

Company profile

Ticker
INDP, NTEC
Exchange
Website
CEO
Jeffrey Meckler
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
Intec Pharma Inc. • Intec Parent, Inc. • Dillon Merger Sub, Inc. • Domestication Merger Sub Ltd. ...

INDP stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

17 May 21
24 Oct 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 11.14M 11.14M 11.14M 11.14M 11.14M 11.14M
Cash burn (monthly) 1.18M (positive/no burn) 1.4M 1.2M 1.44M 889.58K
Cash used (since last report) 7.99M n/a 9.51M 8.14M 9.75M 6.03M
Cash remaining 3.14M n/a 1.62M 2.99M 1.39M 5.1M
Runway (months of cash) 2.7 n/a 1.2 2.5 1.0 5.7

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
16 Sep 20 Walt Addison Linscott Stock Option Ordinary Shares Grant Acquire A No No 0.3215 100,000 32.15K 100,000
16 Sep 20 Nadav Navon Stock Option Ordinary Shares Grant Acquire A No No 0.3215 100,000 32.15K 100,000
16 Sep 20 Nir Sassi Stock Option Ordinary Shares Grant Acquire A No No 0.3215 100,000 32.15K 100,000
15 Jul 20 Kozarich John W Stock Option Ordinary Shares Grant Acquire A No No 0.3075 40,000 12.3K 40,000
15 Jul 20 Hayes William B Stock Option Ordinary Shares Grant Acquire A No No 0.3075 40,000 12.3K 40,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

19.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 13 19 -31.6%
Opened positions 2 4 -50.0%
Closed positions 8 6 +33.3%
Increased positions 1 5 -80.0%
Reduced positions 3 3
13F shares
Current Prev Q Change
Total value 3.55M 5.23M -32.1%
Total shares 1.03M 1.16M -11.9%
Total puts 0 0
Total calls 0 13.4K EXIT
Total put/call ratio
Largest owners
Shares Value Change
AdvisorShares Investments 443.01K $1.54M 0.0%
Intracoastal Capital 265.93K $917K 0.0%
Meitav Dash Investments 120.99K $420K 0.0%
CVI Investments 95K $328K 0.0%
MS Morgan Stanley 34.82K $121K +2984.0%
Gsa Capital Partners 33.29K $116K -29.0%
Squarepoint Ops 19.2K $67K NEW
Citadel Advisors 12.36K $43K -44.7%
WFC Wells Fargo & Co. 253 $1K -92.2%
Advisor 250 $1K 0.0%
Largest transactions
Shares Bought/sold Change
CS Credit Suisse 0 -40.88K EXIT
Sabby Management 0 -37.5K EXIT
MS Morgan Stanley 34.82K +33.69K +2984.0%
BAC Bank Of America 0 -31.68K EXIT
GS Goldman Sachs 0 -26.66K EXIT
Squarepoint Ops 19.2K +19.2K NEW
Geode Capital Management 0 -15.09K EXIT
Gsa Capital Partners 33.29K -13.63K -29.0%
Two Sigma Securities 0 -11.4K EXIT
Citadel Advisors 12.36K -10.01K -44.7%
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. senior Bad
New words: accelerated, acquisition, al, allegedly, allocation, alternative, Arrangement, assignment, Baby, bankruptcy, Body, cancelled, cannabinoid, competent, consent, consummate, consummated, consummation, contractual, convene, conversion, convert, converted, Cooperation, cover, Craig, customary, Davidson, Decoy, decree, deposit, deposited, depreciation, description, Dillon, dismissal, disposition, dissenting, dissolve, distribute, divestment, Dohme, domesticate, domestication, Dronabinol, Eastern, enjoining, entity, entry, equivalent, escrow, explore, federal, Figueroa, final, forfeit, formula, fully, GW, holding, ingredient, Instruction, issuable, Jordan, jurisdiction, lag, left, Marc, Marinol, medicine, merge, merger, merging, merit, Mine, Minh, moot, negotiating, newly, nonpeelable, par, Parent, past, pay, paying, permanently, plaintiff, preferred, prepaid, prescription, prohibiting, prolonged, promptly, proposed, proxy, Qualitative, Quantitative, rare, receipt, requisite, resolved, resource, restraining, restricted, return, Sanchez, satisfaction, Senior, settlement, Sharp, shorter, Simple, sought, Southern, Stub, successor, surviving, synthetic, Tran, unable, undisclosed, unexercised, unvested, vi, vigorously, vii, violated, voluntary, wholly, winding, workplace, York
Removed: absorption, acting, administered, advance, adversely, Andernach, assessed, ATM, August, authorized, bid, buccal, Carni, CBD, cease, China, classification, classified, compare, comparing, complaint, compliance, comply, concentrated, conclusion, concurrent, consistent, Consumer, continuing, correlate, Cowen, criteria, crossover, curtail, custom, daily, declared, deducting, defense, deficiency, delayed, delisted, delisting, demonstrate, dependent, dose, dosed, eligible, endpoint, established, establishment, estimable, event, expire, extend, extension, fail, failure, fewer, force, formulating, forward, gastroscopy, Germany, Giora, globe, goal, good, headcount, health, hearing, human, improved, Index, initially, initiate, institutional, invested, investment, Joseph, label, largely, launch, likelihood, listed, longer, meaningful, meet, met, mid, motion, moving, notification, notified, November, observed, offer, onset, open, pain, partner, partnership, payroll, peak, pharmacokinetic, pivotal, placement, planned, pretrial, Previously, principally, promulgated, protocol, provision, qualification, randomized, recovery, reduced, regain, registered, rejected, requirement, restructured, review, revised, safely, sativa, Sativex, scale, secure, seeking, sell, serve, short, Sinemet, spray, stability, statistically, strain, strategy, study, successful, sufficient, suited, superiority, support, technical, testing, therapeutic, thereof, tolling, turn, underwriting, unsuccessful, validation, variability, vitro, warrant, withdrawn, work, workforce, Wuhan, Zvi

Reddit threads